Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
PaperCitations, authors & open-access status
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 235 citations, 2022 year and bronze oa status.
235
Citations
2022
Year
bronze
OA Status